Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Maximilian Papi"'
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Purpose: To analyze the impact of TP53 mutations on response to first-line tyrosine kinase inhibitors (TKI) in patients with EGFR-mutated non–small cell lung cancer (NSCLC).Experimental Design: 136 EGFR-mutated NSCLC patients receiving first-line T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23d47bb549e33379e5931ad94663ae8
https://doi.org/10.1158/1078-0432.c.6525968
https://doi.org/10.1158/1078-0432.c.6525968
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Relation of TP53 mutations and clinical characteristics of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039484f724f298b67c10c5e59cad9947
https://doi.org/10.1158/1078-0432.22465238
https://doi.org/10.1158/1078-0432.22465238
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Distribution of disruptive and non-disruptive mutations in the different types of TP53 mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e44015238e6e527258bbb5c74f3225
https://doi.org/10.1158/1078-0432.22465241.v1
https://doi.org/10.1158/1078-0432.22465241.v1
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Association between TP53 and EGFR mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327c5e4f2f415859ce8e3780347f776c
https://doi.org/10.1158/1078-0432.22465235
https://doi.org/10.1158/1078-0432.22465235
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
ORR and DCR observed in EGFR exon 19 deleted patients in relation to TP53 mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f63894fe73e9a03752c8c467533ec0
https://doi.org/10.1158/1078-0432.22465232
https://doi.org/10.1158/1078-0432.22465232
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Supplementary legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1776a59a757395036284beb73f44e6
https://doi.org/10.1158/1078-0432.22465229
https://doi.org/10.1158/1078-0432.22465229
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Supplementary Figure 1. a) PFS and b) OS of TP53 exon 8 mutated patients, other TP53 non-disruptive mutated patients and TP53 wt/disruptive mutated patients in the overall case series. c) PFS and d) OS of TP53 exon 8 mutated patients, other TP53 non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1056cf9950064e2534730323974a99f8
https://doi.org/10.1158/1078-0432.22465244.v1
https://doi.org/10.1158/1078-0432.22465244.v1
Autor:
Matteo Canale, Claudio Dazzi, Daniele Calistri, Sara Bravaccini, Maurizio Puccetti, Angelo Delmonte, Maximilian Papi, Paola Ulivi, Claudia Casanova, Alessandro Gamboni, Elisa Chiadini, Alessandra Dubini, Laura Capelli, Lucio Crinò, Marita Mariotti
Publikováno v:
Journal of Thoracic Disease. 10:4858-4864
Background: Molecular diagnostics for non-small cell lung cancer (NSCLC) has become the standard of care for personalized treatment. Epidermal growth factor receptor ( EGFR ) mutation and EML4-ALK translocation represent the two most important altera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29e1551f61e41dd9c0805d62ecfe30be
https://doi.org/10.21037/jtd.2018.07.22
https://doi.org/10.21037/jtd.2018.07.22
Autor:
Laura Capelli, Rita Chiari, Elisabetta Petracci, Maximilian Papi, Dino Amadori, Daniele Calistri, Chiara Bennati, Matteo Canale, Nicoletta De Luigi, Lucio Crinò, Marita Mariotti, Claudia Casanova, Claudio Dazzi, Angelo Delmonte, Paola Ulivi, Vienna Ludovini, Elisa Chiadini, Alessandro Gamboni
Publikováno v:
Clinical Cancer Research. 23:2195-2202
Purpose: To analyze the impact of TP53 mutations on response to first-line tyrosine kinase inhibitors (TKI) in patients with EGFR-mutated non–small cell lung cancer (NSCLC). Experimental Design: 136 EGFR-mutated NSCLC patients receiving first-line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8e7d344b64cfedd8b912a70b8af8751
https://doi.org/10.1158/1078-0432.ccr-16-0966
https://doi.org/10.1158/1078-0432.ccr-16-0966
Autor:
Michele Milella, Annamaria Catino, Luciana Giannone, Francesco Grossi, Diana Giannarelli, Emilio Bria, Adolfo Favaretto, Domenico Galetta, Alessandro Follador, Carlo Genova, Giampaolo Tortora, Erika Rijavec, Gianpiero Fasola, Laura Bonanno, Maximilian Papi, Sara Pilotto, Alessandra Bearz, P. Petrillo, G. Romano, Elisa Roca, Antonio Santo
Considering the frequent expression of somatostatine receptors, we designed the G04.2011 trial to investigate the efficacy of the somatostatine analogue lanreotide in maintenance for SCLC patients after response to standard treatment.A multicenter, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9913c1e5b59a4bed345827a5d204f478
http://hdl.handle.net/10807/153606
http://hdl.handle.net/10807/153606